HeungKong Group Limited
VC
INVESTOR TYPE
2
INVESTMENTS
1
PORTFOLIO
1
EXITS
Primary Investor Type
Venture Capital
Primary Office
- China
HeungKong Group Limited Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| DotBio | 06-Aug-2018 | Seed Round | 00.00 | Drug Discovery | Startup | |
| 00000000 | 14-Jan-2015 | 0000 00000 | 000 | Application Software | Out of Business |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore HeungKong Group Limited’s full profile, request a free trial.
HeungKong Group Limited Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 | 01-Oct-2017 | 000 00 00000000 | Completed |
|
HeungKong Group Limited Team (1)
| Name | Title | Deals | Funds | Boards | Office | Contact Info |
|---|---|---|---|---|---|---|
| Mei Chak | President | China |
HeungKong Group Limited Co-Investors (3)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Futec Biomedical Investments | 1 | ||
| PacificLink Capital | 0 | 0 | |
| Prado SV | 0 | 0 |